Landscapes / Targets
calcineurin
3 drugs act on calcineurin, in 3 active trials · Any stage · updated 19 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs3
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Calcineurin inhibitor immunosuppressant |
Approved | 31 Dec 2027Phase 1 trial completes | |||
| Next date | 31 Dec 2027 · Phase 1 trial completes | ||||
| Also tested for | Age-Related Macular Degeneration | ||||
| Open drug page | |||||
Calcineurin inhibitor immunosuppressant |
Approved | 2 Mar 2029Phase 4 trial completes | |||
| Next date | 2 Mar 2029 · Phase 4 trial completes | ||||
| Also tested for | Lupus Nephritis | ||||
| Open drug page | |||||
— |
Phase 3 | — | |||
| Also tested for | Moderate to Severe Dry Eye | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 3 of 3 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · openFDA updated 19 Nov 2026